Latest Strategy News

St Barbara Limited forecasts a 21% increase in gold production for FY26 at its Simberi Operations, with costs expected between A$4,000 and A$4,400 per ounce. However, key capital investment decisions hinge on unresolved Papua New Guinea tax assessments and mining lease approvals.

TerraCom Limited reports a $43.4 million net loss for FY25, reflecting increased impairment charges and operational challenges, while advancing its strategic Moorlands Project in Australia.

PARKD Limited has completed the first tranche of its $0.78 million placement, issuing over 20 million shares at 3 cents each, while launching a Share Purchase Plan for existing shareholders.

Wellnex Life Limited reported a robust 40.5% revenue increase in FY25, driven by the full-year integration of Pain Away, while margin recovery gains momentum in the second half.

Baumart Holdings has recorded a nearly $1 million impairment on its mining equipment due to halted diamond mining operations and no clear plans for asset redeployment.

Avada Group Limited has updated its FY25 financial results, reducing its loss after tax by $2.04 million due to tax benefit adjustments and reclassification of borrowings, while confirming no impact on operating revenue or cash flow.

FirstWave Cloud Technology has locked in a $2.5 million loan facility to accelerate its AI growth strategy and repay existing debt, complementing a recent $2.85 million equity raise.

Judo Bank has successfully priced a $150 million Tier 2 subordinated notes issuance with a significantly tighter margin, reflecting its strengthened credit profile and strong investor demand.

Energy World Corporation’s final audited results for FY25 reveal a major loan-to-equity reclassification and a reshuffle of director fee liabilities, reshaping the company’s balance sheet.

ParagonCare has released its audited FY25 financial results, confirming steady profit while revealing a significant reclassification of debt and ongoing challenges with a major retail pharmacy receivable.

Altech Batteries has partnered with AMPower to immediately market and distribute sodium nickel chloride batteries across Europe, Australia, and the USA, fast-tracking revenue ahead of its large-scale CERENERGY project in Germany.

Paradigm Biopharmaceuticals has dosed participants in its pivotal Phase 3 trial for knee osteoarthritis across the US and Australia, progressing steadily towards a mid-2026 interim analysis.